Papers/PMID:21088292
Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.
Clinical journal of the American Society of Nephrology : CJASN2011The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
folic acid — decreases incidence of cardiovascular disease (composite)
Evidence strength: very limited.Finding“When pooling the seven trials, folic acid therapy reduced the risk of CVD by 15% (RR, 0.85; 95% CI, 0.76 to 0.96; P = 0.009).”
Quoted verbatim from Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.. - Study
- meta-analysis
- Population
- Patients with ESRD or advanced chronic kidney disease (creatinine clearance below 30 ml/min), seven randomized trials
Effect 0.85 risk ratio, 95% CI 0.76 to 0.96
Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.2011PMID:2108829210.2215/CJN.05310610Permalink